14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.54 Friday, 3rd May 2024 CANF stock ended at $2.09. This is 2.96% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.44% from a day low at $2.02 to a day high of $2.15.
90 days $1.91 $2.71
52 weeks $1.81 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
May 05, 2023 $2.07 $2.15 $2.05 $2.11 37 476
May 04, 2023 $1.85 $2.12 $1.82 $2.12 97 939
May 03, 2023 $1.90 $2.04 $1.90 $1.92 62 794
May 02, 2023 $1.98 $2.02 $1.76 $2.00 772 132
May 01, 2023 $1.74 $1.75 $1.71 $1.75 9 841
Apr 28, 2023 $1.73 $1.74 $1.72 $1.74 20 484
Apr 27, 2023 $1.81 $1.81 $1.72 $1.76 11 414
Apr 26, 2023 $1.73 $1.76 $1.72 $1.75 15 441
Apr 25, 2023 $1.75 $1.80 $1.72 $1.78 18 205
Apr 24, 2023 $1.75 $1.75 $1.68 $1.70 20 794
Apr 21, 2023 $1.74 $1.85 $1.72 $1.76 31 576
Apr 20, 2023 $1.79 $1.80 $1.67 $1.73 24 926
Apr 19, 2023 $1.85 $1.86 $1.75 $1.79 19 301
Apr 18, 2023 $1.76 $1.84 $1.73 $1.80 18 208
Apr 17, 2023 $1.72 $1.87 $1.70 $1.80 97 222
Apr 14, 2023 $1.64 $1.78 $1.64 $1.72 67 522
Apr 13, 2023 $1.74 $1.77 $1.61 $1.73 228 044
Apr 12, 2023 $1.75 $1.76 $1.52 $1.64 168 075
Apr 11, 2023 $2.11 $2.19 $1.57 $1.75 505 486
Apr 10, 2023 $2.28 $2.40 $2.10 $2.20 203 509
Apr 06, 2023 $2.13 $2.34 $2.10 $2.18 6 611
Apr 05, 2023 $2.14 $2.23 $2.05 $2.14 22 712
Apr 04, 2023 $2.32 $2.33 $2.16 $2.16 25 840
Apr 03, 2023 $2.55 $2.31 $2.20 $2.20 40 723
Mar 31, 2023 $2.31 $2.43 $2.21 $2.29 31 418
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT